Cocrystal Pharma Inc (COCP) — Net Asset Quality Index
Cocrystal Pharma Inc (COCP) has a Net Asset Quality Index of 55.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $7.43 Million minus total liabilities of $3.31 Million yields net assets of $4.12 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read COCP liabilities breakdown for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Cocrystal Pharma Inc Net Asset Quality Index Over Time (2007–2025)
This chart shows how Cocrystal Pharma Inc's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of March 2026, the index stands at 55.4%, representing net assets of $4.12 Million against total assets of $7.43 Million USD. For live market cap and overall valuation, see market value of Cocrystal Pharma Inc.
Annual Net Asset Quality Index for Cocrystal Pharma Inc (2007–2025)
The table below presents the year-by-year Net Asset Quality Index for Cocrystal Pharma Inc from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check COCP PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 65.2% | $6.33 Million | $9.71 Million | $3.38 Million | ▼ -5.6 pp |
| 2024 | 70.8% | $9.52 Million | $13.46 Million | $3.93 Million | ▼ -13.6 pp |
| 2023 | 84.4% | $26.38 Million | $31.26 Million | $4.88 Million | ▼ -12.5 pp |
| 2022 | 96.9% | $39.57 Million | $40.84 Million | $1.27 Million | ▼ -0.8 pp |
| 2021 | 97.7% | $77.55 Million | $79.39 Million | $1.84 Million | ▲ +0.9 pp |
| 2020 | 96.8% | $52.51 Million | $54.24 Million | $1.74 Million | ▲ +6.7 pp |
| 2019 | 90.1% | $25.71 Million | $28.53 Million | $2.82 Million | ▼ -7.5 pp |
| 2018 | 97.6% | $66.89 Million | $68.56 Million | $1.67 Million | ▲ +10.8 pp |
| 2017 | 86.8% | $105.40 Million | $121.43 Million | $16.03 Million | ▲ +4.9 pp |
| 2016 | 81.9% | $102.32 Million | $124.88 Million | $22.56 Million | ▲ +7.2 pp |
| 2015 | 74.7% | $167.59 Million | $224.23 Million | $56.64 Million | ▲ +72.2 pp |
| 2014 | 2.6% | $6.65 Million | $259.28 Million | $252.63 Million | ▲ +95.9 pp |
| 2013 | -93.3% | $-6.03 Million | $6.46 Million | $12.48 Million | ▼ -43.9 pp |
| 2012 | -49.5% | $-3.58 Million | $7.24 Million | $10.82 Million | ▼ -12.8 pp |
| 2011 | -36.7% | $-2.77 Million | $7.55 Million | $10.32 Million | ▼ -44.4 pp |
| 2010 | 7.8% | $6.93K | $89.37K | $82.44K | ▼ -40.7 pp |
| 2009 | 48.5% | $54.54K | $112.55K | $58.01K | ▼ -21.0 pp |
| 2008 | 69.5% | $95.34K | $137.20K | $41.86K | ▼ -16.5 pp |
| 2007 | 85.9% | $147.13K | $171.18K | $24.05K | — |